Executive Summary
Ameresco Inc. won a $217M firm fixed-price GSA delivery order for 19-year deep energy retrofits at 25 federal buildings in Region 5, signaling strong federal commitment to energy savings programs. This provides long-term revenue stability with $11.8M in options, but execution risks loom due to the extended timeline and no initial outlays.
Investors should view this as a bullish catalyst for energy services firms targeting government contracts.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal Professional Services Contracts digest from February 23, 2026.
Investment Signals (1)
- Ameresco Lands $217M Long-Term GSA Energy Retrofit Contract (HIGH)▲
Full and open competition award delivers 19-year revenue stream from Jan 2025 to Dec 2043 with base obligation of $217M plus $12M options.
Risk Flags (1)
- Execution [HIGH RISK]▼
Firm fixed-price structure over 19 years exposes Ameresco to cost overruns on deep retrofits with $0 initial outlay indicating early-stage uncertainty.
Opportunities (1)
- ◆
$11.8M in unexercised options could expand contract value to $229M amid National Deep Energy Retrofit Program.
Sector Themes (1)
- ◆
GSA's Round 7 award under NAICS 541330 highlights sustained investment in energy savings performance contracts across Midwest federal buildings.
Watch List (1)
- 👁
{"entity"=>"Ameresco Inc.", "reason"=>"Single large contract dominates period; 19-year duration amplifies materiality for revenue forecasts.", "trigger"=>"Q1 2026 execution updates or option invocations signaling revenue acceleration"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal Professional Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals